Patients achieving low lupus disease activity state, systemic lupus erythematosus disease control or remission showed lower rates of organ damage during longitudinal follow-up: analysis of the Hopkins Lupus Cohort
Open Access
- 11 December 2024
- journal article
- research article
- Published by BMJ in Lupus Science & Medicine
- Vol. 11 (2) , e001206
Abstract
Objective: One key target of treating patients with systemic lupus erythematosus (SLE) is to prevent organ damage. This analysis quantified the association between time spent in four specific SLE low disease activity (LDA) states and organ damage rate.Methods: This retrospective real-world data analysis (GSK Study 207168), undertaken to help contextualise the BLISS-BELIEVE clinical trial, included adults with SLE enrolled for≥1 year in the Hopkins Lupus Cohort and treated with standard therapy in a specialist care centre between 1987 and 2019. LDA states (Lupus Low Disease Activity State (LLDAS), disease control, clinical and complete remissions) were defined using SLE Disease Activity Index (SLEDAI)/Physician Global Assessment scores, prednisone-equivalent dose and medication use criteria combinations. Time spent in each LDA state was expressed as a percentage of total follow-up (0%; >0–0–<25% vs 0%) spent in an LDA state was associated with reduced damage (aRR (95% CI): LLDAS, 0.75 (0.61, 0.91); disease control, 0.80 (0.68, 0.93); clinical remission, 0.73 (0.60, 0.88); complete remission, 0.80 (0.68, 0.93)).Conclusions: Regardless of definition, achieving and maintaining a low disease activity state was associated with reduced organ damage in patients with SLE.Keywords
Funding Information
- The Hopkins Lupus Cohort (NIAMS R01-AR069572 (MP))
- GSK (GSK Study 207168)
This publication has 44 references indexed in Scilit:
- EMBRACE: One Small Story in Lupus—One Giant Challenge in Clinical TrialsACR Open Rheumatology, 2022
- Time to Lupus Low Disease Activity State in the Hopkins Lupus Cohort: Role of African American EthnicityArthritis Care & Research, 2019
- Comparison of Remission and Lupus Low Disease Activity State in Damage Prevention in a United States Systemic Lupus Erythematosus CohortArthritis & Rheumatology, 2018
- Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus ErythematosusArthritis & Rheumatology, 2017
- Defining Low Disease Activity in Systemic Lupus ErythematosusArthritis Care & Research, 2016
- Disease Outcomes in Glucocorticosteroid‐Naive Patients With Systemic Lupus ErythematosusArthritis Care & Research, 2016
- Predictors of organ damage in systemic lupus erythematosus: The Hopkins Lupus CohortArthritis & Rheumatism, 2012
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index in patients with Systemic Lupus ErythematosusArthritis & Rheumatism, 1997
- The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosusArthritis & Rheumatism, 1996